Developmental and stem cell biology's bright future.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
20 Jun 2024
Historique:
received: 20 05 2024
revised: 20 05 2024
accepted: 20 05 2024
medline: 22 6 2024
pubmed: 22 6 2024
entrez: 21 6 2024
Statut: ppublish

Résumé

The next 50 years of developmental biology will illuminate exciting new discoveries but are also poised to provide solutions to important problems society faces. Ten scientists whose work intersects with developmental biology in various capacities tell us about their vision for the future.

Identifiants

pubmed: 38906097
pii: S0092-8674(24)00581-6
doi: 10.1016/j.cell.2024.05.037
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3224-3228

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of interests J.L. has filed patents related to printing vascularized human tissues and organs from stem cell-derived multicellular building blocks. She is a member of the scientific advisory board of Trestle Biotherapeutics, Inc. (a startup company). Trestle has also licensed IP on kidney bioprinting from Harvard, in which the author is listed as an inventor. M.S. has filed patents for reducing aneuploidy in eggs. J.H.H. was granted (through Yeda–Weizmann Institute of Science) patents relevant to the findings and technologies discussed herein (naive and naive-like pluripotency and mouse and human structure-complete embryo models [SEMs]). J.H.H. is a co-founder and chief scientific advisor of Renewal Bio, which has licensed technologies mentioned above. M.Z.G. is an inventor on patents of stem cell-derived models of human and mouse embryos. S.M. is a founder and supervisory and scientific board member of HeartBeat.bio, an IMBA spin-off, based on submitted cardioid (2020) and multi-chamber cardioid (2022) patent applications.

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH